Phase Ⅱ Study of Intercostal Nerve Block With HR18034 for Postsurgical Pain Management
Clinical trial NCT05744674 · UNKNOWN
Trial details
- NCT number
- NCT05744674
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-02-21
- Primary completion
- 2023-06-30
- Enrollment
- 96
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.